The global NGS-based RNA-sequencing market was valued at US$ 2532.5 million in 2023 and is anticipated to reach US$ 7862.7 million by 2030, witnessing a CAGR of 17.4% during the forecast period 2024-2030.

NGS-based RNA-sequencing Market

Gene expression studies can also involve looking at profiles or patterns of expression of several genes. RNA sequencing (RNA-Seq) leverages the advantages of next-generation sequencing (NGS) to detect and quantify RNA in a biological sample at a given point in time.

A significant driver in the NGS-based RNA-sequencing market is the increasing demand for comprehensive and high-throughput analysis of RNA molecules for research and clinical applications. Next-generation sequencing (NGS) technology enables researchers to examine gene expression, identify alternative splicing events, and detect RNA modifications at an unprecedented scale. However, a notable challenge in this market is the need for data analysis and storage solutions. Managing the vast amount of data generated by NGS-based RNA-sequencing while ensuring data accuracy, security, and accessibility poses a significant challenge. Bioinformatics tools, cloud-based solutions, and data management strategies must be continually developed to streamline data analysis and storage processes, facilitating the broader adoption of NGS-based RNA-sequencing in genomics research and precision medicine.

This report aims to provide a comprehensive presentation of the global market for NGS-based RNA-sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NGS-based RNA-sequencing.

Report Scope

The NGS-based RNA-sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global NGS-based RNA-sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the NGS-based RNA-sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of NGS-based RNA-sequencing Market Report

Report Metric	Details
Report Name	NGS-based RNA-sequencing Market
Accounted market size in 2023	US$ 2532.5 million
Forecasted market size in 2030	US$ 7862.7 million
CAGR	17.4%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Sequencing by Synthesis Ion Semiconductor Sequencing Single-molecule Real-time Sequencing Nanopore Sequencing
Segment by Application	Research & Academia Hospitals & Clinics Pharmaceutical & Biotechnology Companies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Illumina, Thermo Fischer Scientific, Oxford Nanopore, Agilent Technologies, BGI, PerkinElmer, QIAGEN, Eurofins Scientific, Roche, Takara Bio, GENEWIZ, Hamilton, Macrogen, Zymo Research, Tecan Genomics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NGS-based RNA-sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is NGS-based RNA-sequencing Market growing?

Ans: The NGS-based RNA-sequencing Market witnessing a CAGR of 17.4% during the forecast period 2024-2030.

What is the NGS-based RNA-sequencing Market size in 2030?

Ans: The NGS-based RNA-sequencing Market size in 2030 will be US$ 7862.7 million.

Who are the main players in the NGS-based RNA-sequencing Market report?

Ans: The main players in the NGS-based RNA-sequencing Market are Illumina, Thermo Fischer Scientific, Oxford Nanopore, Agilent Technologies, BGI, PerkinElmer, QIAGEN, Eurofins Scientific, Roche, Takara Bio, GENEWIZ, Hamilton, Macrogen, Zymo Research, Tecan Genomics

What are the Application segmentation covered in the NGS-based RNA-sequencing Market report?

Ans: The Applications covered in the NGS-based RNA-sequencing Market report are Research & Academia, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others

What are the Type segmentation covered in the NGS-based RNA-sequencing Market report?

Ans: The Types covered in the NGS-based RNA-sequencing Market report are Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global NGS-based RNA-sequencing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Sequencing by Synthesis

1.2.3 Ion Semiconductor Sequencing

1.2.4 Single-molecule Real-time Sequencing

1.2.5 Nanopore Sequencing

1.3 Market by Application

1.3.1 Global NGS-based RNA-sequencing Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Research & Academia

1.3.3 Hospitals & Clinics

1.3.4 Pharmaceutical & Biotechnology Companies

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global NGS-based RNA-sequencing Market Perspective (2019-2030)

2.2 NGS-based RNA-sequencing Growth Trends by Region

2.2.1 Global NGS-based RNA-sequencing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 NGS-based RNA-sequencing Historic Market Size by Region (2019-2024)

2.2.3 NGS-based RNA-sequencing Forecasted Market Size by Region (2025-2030)

2.3 NGS-based RNA-sequencing Market Dynamics

2.3.1 NGS-based RNA-sequencing Industry Trends

2.3.2 NGS-based RNA-sequencing Market Drivers

2.3.3 NGS-based RNA-sequencing Market Challenges

2.3.4 NGS-based RNA-sequencing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top NGS-based RNA-sequencing Players by Revenue

3.1.1 Global Top NGS-based RNA-sequencing Players by Revenue (2019-2024)

3.1.2 Global NGS-based RNA-sequencing Revenue Market Share by Players (2019-2024)

3.2 Global NGS-based RNA-sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by NGS-based RNA-sequencing Revenue

3.4 Global NGS-based RNA-sequencing Market Concentration Ratio

3.4.1 Global NGS-based RNA-sequencing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by NGS-based RNA-sequencing Revenue in 2023

3.5 NGS-based RNA-sequencing Key Players Head office and Area Served

3.6 Key Players NGS-based RNA-sequencing Product Solution and Service

3.7 Date of Enter into NGS-based RNA-sequencing Market

3.8 Mergers & Acquisitions, Expansion Plans

4 NGS-based RNA-sequencing Breakdown Data by Type

4.1 Global NGS-based RNA-sequencing Historic Market Size by Type (2019-2024)

4.2 Global NGS-based RNA-sequencing Forecasted Market Size by Type (2025-2030)

5 NGS-based RNA-sequencing Breakdown Data by Application

5.1 Global NGS-based RNA-sequencing Historic Market Size by Application (2019-2024)

5.2 Global NGS-based RNA-sequencing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America NGS-based RNA-sequencing Market Size (2019-2030)

6.2 North America NGS-based RNA-sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America NGS-based RNA-sequencing Market Size by Country (2019-2024)

6.4 North America NGS-based RNA-sequencing Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe NGS-based RNA-sequencing Market Size (2019-2030)

7.2 Europe NGS-based RNA-sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe NGS-based RNA-sequencing Market Size by Country (2019-2024)

7.4 Europe NGS-based RNA-sequencing Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific NGS-based RNA-sequencing Market Size (2019-2030)

8.2 Asia-Pacific NGS-based RNA-sequencing Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2019-2024)

8.4 Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America NGS-based RNA-sequencing Market Size (2019-2030)

9.2 Latin America NGS-based RNA-sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America NGS-based RNA-sequencing Market Size by Country (2019-2024)

9.4 Latin America NGS-based RNA-sequencing Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa NGS-based RNA-sequencing Market Size (2019-2030)

10.2 Middle East & Africa NGS-based RNA-sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2019-2024)

10.4 Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Illumina

11.1.1 Illumina Company Detail

11.1.2 Illumina Business Overview

11.1.3 Illumina NGS-based RNA-sequencing Introduction

11.1.4 Illumina Revenue in NGS-based RNA-sequencing Business (2019-2024)

11.1.5 Illumina Recent Development

11.2 Thermo Fischer Scientific

11.2.1 Thermo Fischer Scientific Company Detail

11.2.2 Thermo Fischer Scientific Business Overview

11.2.3 Thermo Fischer Scientific NGS-based RNA-sequencing Introduction

11.2.4 Thermo Fischer Scientific Revenue in NGS-based RNA-sequencing Business (2019-2024)

11.2.5 Thermo Fischer Scientific Recent Development

11.3 Oxford Nanopore

11.3.1 Oxford Nanopore Company Detail

11.3.2 Oxford Nanopore Business Overview

11.3.3 Oxford Nanopore NGS-based RNA-sequencing Introduction

11.3.4 Oxford Nanopore Revenue in NGS-based RNA-sequencing Business (2019-2024)

11.3.5 Oxford Nanopore Recent Development

11.4 Agilent Technologies

11.4.1 Agilent Technologies Company Detail

11.4.2 Agilent Technologies Business Overview

11.4.3 Agilent Technologies NGS-based RNA-sequencing Introduction

11.4.4 Agilent Technologies Revenue in NGS-based RNA-sequencing Business (2019-2024)

11.4.5 Agilent Technologies Recent Development

11.5 BGI

11.5.1 BGI Company Detail

11.5.2 BGI Business Overview

11.5.3 BGI NGS-based RNA-sequencing Introduction

11.5.4 BGI Revenue in NGS-based RNA-sequencing Business (2019-2024)

11.5.5 BGI Recent Development

11.6 PerkinElmer

11.6.1 PerkinElmer Company Detail

11.6.2 PerkinElmer Business Overview

11.6.3 PerkinElmer NGS-based RNA-sequencing Introduction

11.6.4 PerkinElmer Revenue in NGS-based RNA-sequencing Business (2019-2024)

11.6.5 PerkinElmer Recent Development

11.7 QIAGEN

11.7.1 QIAGEN Company Detail

11.7.2 QIAGEN Business Overview

11.7.3 QIAGEN NGS-based RNA-sequencing Introduction

11.7.4 QIAGEN Revenue in NGS-based RNA-sequencing Business (2019-2024)

11.7.5 QIAGEN Recent Development

11.8 Eurofins Scientific

11.8.1 Eurofins Scientific Company Detail

11.8.2 Eurofins Scientific Business Overview

11.8.3 Eurofins Scientific NGS-based RNA-sequencing Introduction

11.8.4 Eurofins Scientific Revenue in NGS-based RNA-sequencing Business (2019-2024)

11.8.5 Eurofins Scientific Recent Development

11.9 Roche

11.9.1 Roche Company Detail

11.9.2 Roche Business Overview

11.9.3 Roche NGS-based RNA-sequencing Introduction

11.9.4 Roche Revenue in NGS-based RNA-sequencing Business (2019-2024)

11.9.5 Roche Recent Development

11.10 Takara Bio

11.10.1 Takara Bio Company Detail

11.10.2 Takara Bio Business Overview

11.10.3 Takara Bio NGS-based RNA-sequencing Introduction

11.10.4 Takara Bio Revenue in NGS-based RNA-sequencing Business (2019-2024)

11.10.5 Takara Bio Recent Development

11.11 GENEWIZ

11.11.1 GENEWIZ Company Detail

11.11.2 GENEWIZ Business Overview

11.11.3 GENEWIZ NGS-based RNA-sequencing Introduction

11.11.4 GENEWIZ Revenue in NGS-based RNA-sequencing Business (2019-2024)

11.11.5 GENEWIZ Recent Development

11.12 Hamilton

11.12.1 Hamilton Company Detail

11.12.2 Hamilton Business Overview

11.12.3 Hamilton NGS-based RNA-sequencing Introduction

11.12.4 Hamilton Revenue in NGS-based RNA-sequencing Business (2019-2024)

11.12.5 Hamilton Recent Development

11.13 Macrogen

11.13.1 Macrogen Company Detail

11.13.2 Macrogen Business Overview

11.13.3 Macrogen NGS-based RNA-sequencing Introduction

11.13.4 Macrogen Revenue in NGS-based RNA-sequencing Business (2019-2024)

11.13.5 Macrogen Recent Development

11.14 Zymo Research

11.14.1 Zymo Research Company Detail

11.14.2 Zymo Research Business Overview

11.14.3 Zymo Research NGS-based RNA-sequencing Introduction

11.14.4 Zymo Research Revenue in NGS-based RNA-sequencing Business (2019-2024)

11.14.5 Zymo Research Recent Development

11.15 Tecan Genomics

11.15.1 Tecan Genomics Company Detail

11.15.2 Tecan Genomics Business Overview

11.15.3 Tecan Genomics NGS-based RNA-sequencing Introduction

11.15.4 Tecan Genomics Revenue in NGS-based RNA-sequencing Business (2019-2024)

11.15.5 Tecan Genomics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Illumina Inc

Thermo Fischer Scientific

List of Tables

Table 1. Global NGS-based RNA-sequencing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Sequencing by Synthesis

Table 3. Key Players of Ion Semiconductor Sequencing

Table 4. Key Players of Single-molecule Real-time Sequencing

Table 5. Key Players of Nanopore Sequencing

Table 6. Global NGS-based RNA-sequencing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global NGS-based RNA-sequencing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global NGS-based RNA-sequencing Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global NGS-based RNA-sequencing Market Share by Region (2019-2024)

Table 10. Global NGS-based RNA-sequencing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global NGS-based RNA-sequencing Market Share by Region (2025-2030)

Table 12. NGS-based RNA-sequencing Market Trends

Table 13. NGS-based RNA-sequencing Market Drivers

Table 14. NGS-based RNA-sequencing Market Challenges

Table 15. NGS-based RNA-sequencing Market Restraints

Table 16. Global NGS-based RNA-sequencing Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global NGS-based RNA-sequencing Market Share by Players (2019-2024)

Table 18. Global Top NGS-based RNA-sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-sequencing as of 2023)

Table 19. Ranking of Global Top NGS-based RNA-sequencing Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by NGS-based RNA-sequencing Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players NGS-based RNA-sequencing Product Solution and Service

Table 23. Date of Enter into NGS-based RNA-sequencing Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global NGS-based RNA-sequencing Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global NGS-based RNA-sequencing Revenue Market Share by Type (2019-2024)

Table 27. Global NGS-based RNA-sequencing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global NGS-based RNA-sequencing Revenue Market Share by Type (2025-2030)

Table 29. Global NGS-based RNA-sequencing Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global NGS-based RNA-sequencing Revenue Market Share by Application (2019-2024)

Table 31. Global NGS-based RNA-sequencing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global NGS-based RNA-sequencing Revenue Market Share by Application (2025-2030)

Table 33. North America NGS-based RNA-sequencing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America NGS-based RNA-sequencing Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America NGS-based RNA-sequencing Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe NGS-based RNA-sequencing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe NGS-based RNA-sequencing Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe NGS-based RNA-sequencing Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific NGS-based RNA-sequencing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific NGS-based RNA-sequencing Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America NGS-based RNA-sequencing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America NGS-based RNA-sequencing Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America NGS-based RNA-sequencing Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa NGS-based RNA-sequencing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa NGS-based RNA-sequencing Market Size by Country (2025-2030) & (US$ Million)

Table 48. Illumina Company Detail

Table 49. Illumina Business Overview

Table 50. Illumina NGS-based RNA-sequencing Product

Table 51. Illumina Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)

Table 52. Illumina Recent Development

Table 53. Thermo Fischer Scientific Company Detail

Table 54. Thermo Fischer Scientific Business Overview

Table 55. Thermo Fischer Scientific NGS-based RNA-sequencing Product

Table 56. Thermo Fischer Scientific Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)

Table 57. Thermo Fischer Scientific Recent Development

Table 58. Oxford Nanopore Company Detail

Table 59. Oxford Nanopore Business Overview

Table 60. Oxford Nanopore NGS-based RNA-sequencing Product

Table 61. Oxford Nanopore Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)

Table 62. Oxford Nanopore Recent Development

Table 63. Agilent Technologies Company Detail

Table 64. Agilent Technologies Business Overview

Table 65. Agilent Technologies NGS-based RNA-sequencing Product

Table 66. Agilent Technologies Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)

Table 67. Agilent Technologies Recent Development

Table 68. BGI Company Detail

Table 69. BGI Business Overview

Table 70. BGI NGS-based RNA-sequencing Product

Table 71. BGI Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)

Table 72. BGI Recent Development

Table 73. PerkinElmer Company Detail

Table 74. PerkinElmer Business Overview

Table 75. PerkinElmer NGS-based RNA-sequencing Product

Table 76. PerkinElmer Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)

Table 77. PerkinElmer Recent Development

Table 78. QIAGEN Company Detail

Table 79. QIAGEN Business Overview

Table 80. QIAGEN NGS-based RNA-sequencing Product

Table 81. QIAGEN Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)

Table 82. QIAGEN Recent Development

Table 83. Eurofins Scientific Company Detail

Table 84. Eurofins Scientific Business Overview

Table 85. Eurofins Scientific NGS-based RNA-sequencing Product

Table 86. Eurofins Scientific Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)

Table 87. Eurofins Scientific Recent Development

Table 88. Roche Company Detail

Table 89. Roche Business Overview

Table 90. Roche NGS-based RNA-sequencing Product

Table 91. Roche Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)

Table 92. Roche Recent Development

Table 93. Takara Bio Company Detail

Table 94. Takara Bio Business Overview

Table 95. Takara Bio NGS-based RNA-sequencing Product

Table 96. Takara Bio Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)

Table 97. Takara Bio Recent Development

Table 98. GENEWIZ Company Detail

Table 99. GENEWIZ Business Overview

Table 100. GENEWIZ NGS-based RNA-sequencing Product

Table 101. GENEWIZ Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)

Table 102. GENEWIZ Recent Development

Table 103. Hamilton Company Detail

Table 104. Hamilton Business Overview

Table 105. Hamilton NGS-based RNA-sequencing Product

Table 106. Hamilton Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)

Table 107. Hamilton Recent Development

Table 108. Macrogen Company Detail

Table 109. Macrogen Business Overview

Table 110. Macrogen NGS-based RNA-sequencing Product

Table 111. Macrogen Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)

Table 112. Macrogen Recent Development

Table 113. Zymo Research Company Detail

Table 114. Zymo Research Business Overview

Table 115. Zymo Research NGS-based RNA-sequencing Product

Table 116. Zymo Research Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)

Table 117. Zymo Research Recent Development

Table 118. Tecan Genomics Company Detail

Table 119. Tecan Genomics Business Overview

Table 120. Tecan Genomics NGS-based RNA-sequencing Product

Table 121. Tecan Genomics Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)

Table 122. Tecan Genomics Recent Development

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Global NGS-based RNA-sequencing Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global NGS-based RNA-sequencing Market Share by Type: 2023 VS 2030

Figure 3. Sequencing by Synthesis Features

Figure 4. Ion Semiconductor Sequencing Features

Figure 5. Single-molecule Real-time Sequencing Features

Figure 6. Nanopore Sequencing Features

Figure 7. Global NGS-based RNA-sequencing Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global NGS-based RNA-sequencing Market Share by Application: 2023 VS 2030

Figure 9. Research & Academia Case Studies

Figure 10. Hospitals & Clinics Case Studies

Figure 11. Pharmaceutical & Biotechnology Companies Case Studies

Figure 12. Others Case Studies

Figure 13. NGS-based RNA-sequencing Report Years Considered

Figure 14. Global NGS-based RNA-sequencing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global NGS-based RNA-sequencing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global NGS-based RNA-sequencing Market Share by Region: 2023 VS 2030

Figure 17. Global NGS-based RNA-sequencing Market Share by Players in 2023

Figure 18. Global Top NGS-based RNA-sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-sequencing as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by NGS-based RNA-sequencing Revenue in 2023

Figure 20. North America NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America NGS-based RNA-sequencing Market Share by Country (2019-2030)

Figure 22. United States NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe NGS-based RNA-sequencing Market Share by Country (2019-2030)

Figure 26. Germany NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific NGS-based RNA-sequencing Market Share by Region (2019-2030)

Figure 34. China NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America NGS-based RNA-sequencing Market Share by Country (2019-2030)

Figure 42. Mexico NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa NGS-based RNA-sequencing Market Share by Country (2019-2030)

Figure 46. Turkey NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Illumina Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)

Figure 49. Thermo Fischer Scientific Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)

Figure 50. Oxford Nanopore Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)

Figure 51. Agilent Technologies Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)

Figure 52. BGI Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)

Figure 53. PerkinElmer Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)

Figure 54. QIAGEN Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)

Figure 55. Eurofins Scientific Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)

Figure 56. Roche Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)

Figure 57. Takara Bio Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)

Figure 58. GENEWIZ Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)

Figure 59. Hamilton Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)

Figure 60. Macrogen Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)

Figure 61. Zymo Research Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)

Figure 62. Tecan Genomics Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions